MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
MannKind operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MannKind's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.05M, down 123.3% year over year. For fiscal 2025 it was $18.26M, down 57.1% from the year before. The highest annual figure on record is $42.51M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.26M | -57.1% |
| FY2024 | Dec 31, 2024 | $42.51M | +24.7% |
| FY2023 | Dec 31, 2023 | $34.09M | – |
| FY2022 | Dec 31, 2022 | -$80.68M | – |
| FY2021 | Dec 31, 2021 | -$61.71M | – |
| FY2020 | Dec 31, 2020 | -$28.13M | – |
| FY2019 | Dec 31, 2019 | -$88.48M | – |
| FY2018 | Dec 31, 2018 | -$37.73M | – |
| FY2017 | Dec 31, 2017 | -$64.78M | – |
| FY2016 | Dec 31, 2016 | -$78.09M | – |
| FY2015 | Dec 31, 2015 | -$57.23M | -1500.7% |
| FY2014 | Dec 31, 2014 | $4.09M | – |
| FY2013 | Dec 31, 2013 | -$128.73M | – |
| FY2012 | Dec 31, 2012 | -$119.86M | – |
| FY2011 | Dec 31, 2011 | -$123.84M | – |
| FY2010 | Dec 31, 2010 | -$148.65M | – |
| FY2009 | Dec 31, 2009 | -$184.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.37M | -305.3% |
| Q1 FY2026 | Mar 31, 2026 | -$5.37M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.96M | -135.1% |
| Q3 FY2025 | Sep 30, 2025 | $23.64M | +153.3% |
| Q2 FY2025 | Jun 30, 2025 | $8.95M | +133.5% |
| Q1 FY2025 | Mar 31, 2025 | -$6.38M | -195.1% |
| Q4 FY2024 | Dec 31, 2024 | $22.64M | +4.5% |
| Q3 FY2024 | Sep 30, 2024 | $9.33M | +7.7% |
| Q2 FY2024 | Jun 30, 2024 | $3.83M | +47.7% |
| Q1 FY2024 | Mar 31, 2024 | $6.70M | +479.8% |
| Q4 FY2023 | Dec 31, 2023 | $21.68M | – |
| Q3 FY2023 | Sep 30, 2023 | $8.66M | – |
| Q2 FY2023 | Jun 30, 2023 | $2.60M | – |
| Q1 FY2023 | Mar 31, 2023 | $1.16M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$28.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$31.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.35M | -5354.0% |
| Q3 FY2021 | Sep 30, 2021 | -$15.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$21.45M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.73M | – |
| Q4 FY2020 | Dec 31, 2020 | $235.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.46M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.68M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.11M | -120.4% |
| Q3 FY2019 | Sep 30, 2019 | -$52.05M | – |
| Q2 FY2019 | Jun 30, 2019 | -$19.73M | – |
| Q1 FY2019 | Mar 31, 2019 | -$11.60M | – |
| Q4 FY2018 | Dec 31, 2018 | $24.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.92M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$21.65M | -354.5% |
| Q4 FY2017 | Dec 31, 2017 | -$29.98M | – |
| Q3 FY2017 | Sep 30, 2017 | -$23.27M | – |
| Q2 FY2017 | Jun 30, 2017 | -$20.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.51M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.75M | – |
| Q3 FY2016 | Sep 30, 2016 | -$23.07M | – |
See a number that looks wrong?